CoreCap Advisors’s Vaxart VXRT Stock Holding History

CoreCap Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4	Closed	-$3	–	2748
2024 Q2	$3	Hold	4	–	–	﹤0.01%	1596
2024 Q1	$5	Buy	+4	New	+$4	﹤0.01%	2516
2022 Q4	$4	Buy	+4	New	+$6	﹤0.01%	2387
2022 Q3	–	Sell	-4	Closed	–	–	2084
2022 Q2	$0	Buy	+4	New	+$15	﹤0.01%	2290
2022 Q1	–	Sell	-1,004	Closed	-$6K	–	2086
2021 Q4	$6K	Buy	+1,004	New	+$6.86K	﹤0.01%	1723

Other funds holding VXRT

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CoreCap Advisors's VXRT Position: Q3 2024 in Review

CoreCap Advisors sold out of Vaxart (VXRT) in Q3 2024, closing a stake of 4 shares — an estimated $3 sold.

CoreCap Advisors first reported a position in VXRT in Q4 2021 and held it in 5 quarters. The position peaked at $6K in Q4 2021. 100 funds tracked by Wall St. Rank hold VXRT as of Q3 2024.

CoreCap Advisors reported no remaining Vaxart position as of Q3 2024 after selling out during the quarter.
CoreCap Advisors sold 4 Vaxart shares in Q3 2024, an estimated $3.
CoreCap Advisors first reported a position in Vaxart in Q4 2021 and held it in 5 quarters.
CoreCap Advisors's Vaxart position peaked at $6K in Q4 2021.
100 funds tracked by Wall St. Rank held Vaxart as of Q3 2024.

Based on CoreCap Advisors's 13F filing for Q3 2024, filed 8 Nov 2024.